Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
43.49 |
47.23 |
57.83 |
60.15 |
55.45 |
Operating profit |
2.67 |
3.40 |
8.37 |
8.64 |
5.44 |
Interest |
0.22 |
0.23 |
0.22 |
0.15 |
0.20 |
Gross profit |
4.94 |
5.69 |
10.42 |
10.48 |
7.80 |
EPS (Rs) |
1.34 |
1.51 |
2.85 |
2.85 |
2.14 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
2.49 |
2.52 |
2.27 |
2.00 |
2.56 |
Stock adjustment |
1.81 |
-0.29 |
1.20 |
1.17 |
-1.62 |
Raw material |
3.79 |
5.88 |
4.91 |
7.53 |
6.32 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
11.45 |
11.64 |
11.70 |
13.70 |
13.21 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
23.77 |
26.61 |
31.65 |
29.12 |
32.10 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.40 |
0.41 |
0.46 |
0.39 |
0.48 |
Taxation |
0.99 |
1.32 |
2.49 |
2.61 |
1.72 |
Net profit / loss |
3.55 |
3.96 |
7.47 |
7.48 |
5.60 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
13.22 |
13.14 |
13.10 |
13.10 |
13.10 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
6.14 |
7.19 |
14.47 |
14.36 |
9.81 |
GPM (%) |
10.74 |
11.44 |
17.33 |
16.87 |
13.45 |
NPM (%) |
7.72 |
7.97 |
12.43 |
12.03 |
9.66 |